193 related articles for article (PubMed ID: 31085373)
1. Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells.
Haider MR; Ahmad K; Siddiqui N; Ali Z; Akhtar MJ; Fuloria N; Fuloria S; Ravichandran M; Yar MS
Bioorg Chem; 2019 Jul; 88():102962. PubMed ID: 31085373
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity.
Nunhart P; Konkoľová E; Janovec L; Jendželovský R; Vargová J; Ševc J; Matejová M; Miltáková B; Fedoročko P; Kozurkova M
Bioorg Chem; 2020 Jan; 94():103393. PubMed ID: 31679839
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Majumdar P; Bathula C; Basu SM; Das SK; Agarwal R; Hati S; Singh A; Sen S; Das BB
Eur J Med Chem; 2015 Sep; 102():540-51. PubMed ID: 26312433
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons.
Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS
Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
Ismail MA; Tratrat C; Haroun MG
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
Zhang C; Qu Y; Niu B
Bioorg Med Chem; 2016 Nov; 24(22):5781-5786. PubMed ID: 27667553
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
10. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.
Zhang C; Li S; Ji L; Liu S; Li Z; Li S; Meng X
Bioorg Med Chem Lett; 2015 Oct; 25(20):4693-6. PubMed ID: 26384290
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.
Yu LM; Zhang XR; Li XB; Yang Y; Wei HY; He XX; Gu LQ; Huang ZS; Pommier Y; An LK
Eur J Med Chem; 2015 Aug; 101():525-33. PubMed ID: 26188908
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Atlıd Ö; Atlı Eklioğlu Ö; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1657-1673. PubMed ID: 32811204
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.
Yu Q; Yang H; Zhu TW; Yu LM; Chen JW; Gu LQ; Huang ZS; An LK
Eur J Med Chem; 2018 May; 152():195-207. PubMed ID: 29705710
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
16. Molecular Design, Synthesis and Docking Study of Alkyl and Benzyl Derivatives of Robustic Acid as Topoisomerase I Inhibitors.
Chen R; Huang J; Jaiswal Y; Wei J; Huo L; Xia X; Zhong J; Williams L; Huang M; Liang Y
Chem Biodivers; 2020 Mar; 17(3):e1900556. PubMed ID: 31943759
[TBL] [Abstract][Full Text] [Related]
17. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
18. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
[TBL] [Abstract][Full Text] [Related]
19. Novel securinine derivatives as topoisomerase I based antitumor agents.
Hou W; Wang ZY; Peng CK; Lin J; Liu X; Chang YQ; Xu J; Jiang RW; Lin H; Sun PH; Chen WM
Eur J Med Chem; 2016 Oct; 122():149-163. PubMed ID: 27344492
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
